CBX7 is involved in the progression of cervical cancer through the ITGβ3/TGFβ1/AKT pathway

Ping Tian1,2, Jinglan Deng3, Cailing Ma1,4

  • 1State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Xinjiang Medical University, Urumqi, Xinjiang Uyghur Autonomous Region 830054, P.R. China.

Oncology Letters
|November 29, 2023
PubMed

Insights

Chromobox protein homolog 7 (CBX7) downregulation promotes cervical cancer progression by enhancing cell migration and invasion. CBX7 deficiency inhibits apoptosis and tumor growth via the ITGβ3/TGFβ1/AKT pathway.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Chromobox protein homolog 7 (CBX7) is a tumor suppressor in human cancers.
  • CBX7 downregulation correlates with poor prognosis and aggressiveness in various cancers.
  • The role of CBX7 in cervical cancer pathogenesis is not well understood.

Purpose of the Study:

  • To investigate the function and mechanism of CBX7 in cervical cancer.
  • To determine how CBX7 influences cervical cancer cell behavior and tumor growth.
  • To elucidate the signaling pathways involved in CBX7-mediated regulation.

Main Methods:

  • Utilized lentivirus and siRNA for stable CBX7 knockdown in cervical cancer cells.
  • Established SiHa xenograft models for in vivo studies.
  • Assessed cell proliferation, migration, invasion, and apoptosis using in vitro and in vivo assays.
  • Quantified gene and protein expression levels (CBX7, ITGβ3, TGFβ1, PI3K, AKT, E-cad, VIM) via western blot and RT-qPCR.
  • Investigated the role of TGFβ1 by shRNA-mediated knockdown.

Main Results:

  • CBX7 knockdown significantly promoted cervical cancer cell proliferation, migration, and invasion.
  • CBX7 deficiency inhibited apoptosis and accelerated tumor growth in vivo.
  • CBX7 expression was negatively correlated with ITGβ3, TGFβ1, PI3K, AKT, p-AKT, and VIM, and positively correlated with E-cadherin.
  • Knockdown of TGFβ1 reversed the effects of CBX7 knockdown on cell proliferation, apoptosis, and pathway-related gene expression.

Conclusions:

  • CBX7 downregulation enhances cervical cancer cell migration and invasion while suppressing apoptosis.
  • The tumor-suppressive role of CBX7 in cervical cancer is mediated through the ITGβ3/TGFβ1/AKT signaling pathway.
  • Targeting CBX7 or its downstream effectors may offer therapeutic strategies for cervical cancer.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K